|ITCI -- USA Stock|| |
USD 20.45 0.05 0.25%
Co-Founder, Chairman, CEO and Pres
Dr. Sharon Mates, Ph.D., is Chairman of the Board, President, Chief Executive Officer of IntraCellular Therapies, Inc. Dr. Mates cofounded ITI in May 2002. Prior to cofounding ITI, Dr. Mates was a cofounder of Functional Genetics, and served as its Chairman and Chief Executive Officer from December 2000 until August 2003. From 19891998 Dr. Mates was the President and a board member of North American Vaccine Inc. and its predecessor companies. She has served on several boards, and recently completed a board membership and a twoyear chairmanship of the Board of the New York Biotechnology Association. Dr. Mates has also served on the Advisory Council of the Center for Society and Health at the Harvard School of Public Health, the Board of Visitors of the Biotechnology Institute of the University of Maryland and the board of directors of Gildas Club of New York. Earlier in her career, Dr. Mates spent several years as a research analyst and investment banker, and as an advisor to the life sciences industry
Age: 63 Chairman Since 2014 Ph.D
Mates received her B.S. from the Ohio State University and her Ph.D. from the University of Washington, and completed her postdoctoral fellowships at The Massachusetts General Hospital and Harvard Medical School.